Location History:
- Malle, BE (2015 - 2019)
- Westmalle, BE (2020)
Company Filing History:
3 out of 7 
2 out of 108 
Years Active: 2015-2020
Title: Jan Hoflack: Innovator in Kinase Inhibitors
Introduction
Jan Hoflack is a notable inventor based in Malle, Belgium. He has made significant contributions to the field of kinase inhibitors, holding a total of four patents. His work focuses on developing macrocyclic compounds that have potential applications in the diagnosis and treatment of various diseases.
Latest Patents
Hoflack's latest patents include innovative compounds that act as inhibitors for specific kinases. One of his notable inventions is related to macrocyclic RIP2 kinase inhibitors. This invention involves compounds and compositions that target RIP2 and its mutants, offering potential for diagnosing, preventing, and treating diseases associated with RIP2 kinase activity. Another significant patent is for macrocyclic LRRK2 kinase inhibitors. This invention presents novel compounds that inhibit LRRK2, which is crucial for addressing neurological disorders such as Parkinson's disease and Alzheimer's disease.
Career Highlights
Throughout his career, Jan Hoflack has worked with prominent companies in the pharmaceutical industry. He has been associated with Oncodesign SA and Ipsen Pharma S.A.S., where he has contributed to the development of innovative therapeutic solutions. His expertise in kinase inhibitors has positioned him as a valuable asset in the field of medicinal chemistry.
Collaborations
Hoflack has collaborated with several professionals in his field, including Petra Blom and Pascal Benderitter. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Jan Hoflack is a distinguished inventor whose work in kinase inhibitors has the potential to impact the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.